LCTX vs MSFT: Which Stock is Better?
Side-by-side comparison of Lineage Cell Therapeutics Inc and Microsoft Corp in 2026
LCTX
Lineage Cell Therapeutics Inc
$1.71
MSFT
Microsoft Corp
$430.11
Key Metrics Comparison
| Metric | LCTX | MSFT | Winner |
|---|---|---|---|
| Market Cap | $408.50M | N/A | LCTX |
| P/E Ratio | N/A | 26.32 | MSFT |
| EPS (TTM) | $N/A | $15.97 | MSFT |
| Revenue Growth | 1.3% | 0.2% | LCTX |
| Gross Margin | -22.8% | 68.6% | MSFT |
Analyze LCTX
Full quant analysis
Analyze MSFT
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is LCTX or MSFT a better investment?
Comparing LCTX and MSFT: Lineage Cell Therapeutics Inc has a market cap of $408.50M while Microsoft Corp has N/A. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between LCTX and MSFT?
LCTX (Lineage Cell Therapeutics Inc) and MSFT (Microsoft Corp) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: LCTX or MSFT?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: LCTX or MSFT?
LCTX has higher revenue growth at 1.3% vs 0.2% for MSFT.
Which company is more profitable: LCTX or MSFT?
Microsoft Corp (MSFT) has higher gross margins at 68.6% compared to -22.8% for LCTX.
Which is the larger company: LCTX or MSFT?
Lineage Cell Therapeutics Inc (LCTX) is larger with a market cap of $408.50M compared to N/A for MSFT.
Should I buy LCTX or MSFT in 2026?
Both LCTX and MSFT have investment merit. LCTX trades at $1.71 while MSFT trades at $430.11. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between LCTX and MSFT stock?
Key differences: Market Cap ($408.50M vs N/A), P/E Ratio (N/A vs 26.3x), Revenue Growth (1.3% vs 0.2%), Gross Margin (-22.8% vs 68.6%).